Syndax pharmaceuticals inc.

Major-Pharmaceuticals

SNDX


35 Gatehouse Drive
Waltham , MA 02451

Executive/
Director

Price

  • Last Close
  • $ 14.38
    $ +0.31 2.17 %
    Jan 3, 2025
  • 52-Week High/Low
  • $24.57 - $11.39
  • YTD
  • 0%

  • Trading Volume
  • 40,115
  • Market Cap Full
  • $ 1B
  • Shares Outstanding
  • 69.6M
    Oct 27, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 91.4% 62.4% 18% -5% 0.5% -20.6% -17% 10% 8.9% -
Q2 1.8% -50% 88.6% 4% -23.2% 10.7% -0.9% -14.5% - -
Q3 -16.3% 14.6% -13.7% 8% 11.3% 24.9% -30.6% -11.2% - -
Q4 -32.3% -47.2% 15% 55.4% 14.6% 5.9% 60.1% -38.6% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 8.9% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    0%22%-49%100%150%-2%16%-15%-39%9%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 0.71 -0.79 -0.53 -0.56 -0.54 -0.63 -0.59
Q2 0.70 -0.74 -0.47 -0.42 -0.44 -0.62 -0.64
Q3 0.68 -0.68 -0.41 -0.46 -0.4 -0.58 -0.73
Q4 0.80 -0.71 -0.43 -0.43 1.84 -0.63 -
A 2.9 -2.9 -1.8 -1.9 0.5 -2.5 -1.96

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 25 30.2 48.2 55 0.1
Jun 24.7 27.1 36.1 48.2 56.2 68.8
Sep 23.4 27.1 38.5 48.6 56.6 69.5
Dec 24.8 27.1 40.9 49.4 60.2 69.6

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - 2 - -
Total Asset Turnover - 0.3 - - -
Leverage
Debt Ratio - - 0.1 - -
Debt – Equity Ratio - 0.1 0.1 - -
Interest Coverage 50.7 26 -35.5 29 38
Equity multiplier - - - - -